HTR2A and major depressive disorder: Recently, classic psychedelics (serotonin 2A or 5-HT2A agonists such as psilocybin, lysergic acid diethylamide or LSD, and N,N-dimethyltryptamine or DMT) have shown potential efficacy for treating a variety of psychiatric disorders [1–6], including major depressive disorder (MDD).